[1]
Mehić, B., Stanetić, M., Tinjić, L. and Smoljanović, V. 2008. Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer. Bosnian Journal of Basic Medical Sciences. 8, 4 (Nov. 2008), 386-390. DOI:https://doi.org/10.17305/bjbms.2008.2905.